Overview
Philips Neuro, a division of Royal Philips, offers a comprehensive portfolio of EEG systems, long-term monitoring solutions, and diagnostic neurology software used in hospital neurology departments and ICUs worldwide. Their Alice and Natus-integrated platforms support epilepsy monitoring, sleep studies, and intraoperative neuromonitoring.
Philips Neuro is a division of Royal Philips dedicated to the development and commercialization of neurodiagnostic technologies for clinical and hospital settings. The division offers a comprehensive portfolio of EEG acquisition systems, long-term monitoring platforms, and advanced neurology software designed to support clinicians in diagnosing and managing complex neurological conditions. Their solutions span a broad range of clinical applications, including epilepsy monitoring, sleep disorder diagnostics, and intraoperative neuromonitoring. Built on legacy platforms including the Alice sleep diagnostics system and capabilities integrated through the acquisition of Natus Medical, Philips Neuro delivers end-to-end neurodiagnostic workflows for neurology departments and intensive care units worldwide.
As a division of Royal Philips, a publicly traded global health technology company listed on the NYSE under the ticker PHG, Philips Neuro benefits from the scale, infrastructure, and R&D investment of one of the world's largest healthcare companies. The integration of the Natus Medical neurodiagnostics portfolio significantly expanded Philips Neuro's reach, adding established clinical tools and a broad installed base across hospitals and monitoring centers globally. Their systems are deployed in neurology departments and ICUs across multiple continents, supporting both routine diagnostic procedures and complex continuous monitoring requirements. This broad clinical footprint positions Philips Neuro among the most widely adopted neurodiagnostic platform providers in the industry.
Philips Neuro represents a critical pillar of the broader neurodiagnostics ecosystem, bringing institutional credibility and clinical-grade technology to a field that increasingly demands scalable and integrated solutions. As neurological conditions such as epilepsy, traumatic brain injury, and sleep disorders continue to represent a significant global burden, the need for reliable, hospital-ready monitoring infrastructure has never been greater. Philips Neuro's ability to combine hardware, software, and data management within a unified clinical workflow addresses a foundational gap in how neurological care is delivered at scale. Their continued investment in this space signals the growing strategic importance of neurodiagnostics within the broader trajectory of precision neurology and brain health management.
More in Neurodiagnostics
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🔬 Neurodiagnostics
Location
Amsterdam, Netherlands
Funding
Public · NYSE: PHG
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →